??? ????⭐??? ????⭐?? ??? ???? ????, ??, ??? ? ???? ??? ?????.

1. ??? ????⭐??? ????⭐?? ??? ???? ????, ??, ??? ? ???? ??? ?????.?? ?????(Laurent Kleitman) ??? ???? ?? ?? CEO? “?????? ???? ??? ??? ???? ??”??? “??? ???, ??? ???? ??, ??? ?? ?? ?? ??? ?? ?? ??? ???”? ????. ???????? ??? ?? ??? ???? ??? 2? ???X???? ?? ?? ‘?? ? ? ‘G’?: ????? ??? ????(Nothing but a ‘G’ Thang: The Art and Archive of G-Dragon)‘? ?? ????.

2. ??????? ????⭐??? ????⭐South Korea’s GI Innovation said on Monday that it signed a clinical trial collaboration and supply agreement with global pharmaceutical company MSD.Under the agreement, the duo will conduct a trial to evaluate the efficacy of their immunotherapies in combination. The two companies will also evaluate the efficacy of GI Innovation’s immuno-oncology drug GI-102 in combination with MSD’s Keytruda in patients with resistant liver cancer, melanoma, and kidney cancer. 937 win???? ??? ????? “??? ??? ??? ?? ???? ?? ????”? ???????? ???? ??? “???? ???? ??? ???? ?? ?? ????? ???”? ???. ??? ?? ??? “?? API ??? ?? ???? ??? ?? ??? ???? ????, ???? ???? ??? ? ?? ? ???”?? “???? ?????? ??? ??? ??? ? ??? ??? API? ????, ?? ???? ?? ??? ??? ???? ? ??? ???”?? ???.

3. ??? ?? ?????? ????⭐??? ????⭐???? “?? ???? ??? ????? ??? ?? ?? ???. ?? ??? ?? ??? ??? ?? ? ????? ??? ?? ???, ? ?? ?? ??? ???”?? ?? ?? ??? ????.

4. ?????? ????⭐??? ????⭐?????South Korea’s GI Innovation said on Monday that it signed a clinical trial collaboration and supply agreement with global pharmaceutical company MSD.Under the agreement, the duo will conduct a trial to evaluate the efficacy of their immunotherapies in combination. The two companies will also evaluate the efficacy of GI Innovation’s immuno-oncology drug GI-102 in combination with MSD’s Keytruda in patients with resistant liver cancer, melanoma, and kidney cancer.